Haisco Pharmaceutical Group: Announcement on Additional Provisional Proposals and Supplementary Notices for the 2023 Annual General Meeting of Shareholders
Apr 29 23:49 ET
Haisco Pharmaceutical Group: Announcement on licensing and termination of the riluzole oral solution EXSERVAN project and preparation for impairment
Apr 29 23:49 ET
Haisco Pharmaceutical Group: Notice on the establishment of a subsidiary in Shannan City, Tibet Autonomous Region
Apr 29 23:49 ET
Haisco Pharmaceutical Group: Notice on amending the “Articles of Association”
Apr 29 23:49 ET
HiCisco: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Management
Apr 19 12:00 ET
HiCisco: Internal Control Self-Assessment Report
Apr 19 12:00 ET
HiCisco: Announcement on Using Idle Own Funds for Delegated Financial Management
Apr 19 12:00 ET
HiCisco: Notice of Annual General Meeting of Shareholders
Apr 19 12:00 ET
HiCisco: Accounting Services Selection and Employment System
Apr 19 12:00 ET
HiCisco: Announcement on obtaining funds to support industrial development
Mar 31 12:00 ET
HiCisco: Announcement on Obtaining the “Notice of Acceptance” of the IND Application for the Innovative Drug HSK42360 Tablets
Mar 27 12:00 ET
HiCisco: Announcement on capital increase to subsidiary HiCisco (Hong Kong) Holdings
Feb 27 11:00 ET
HiCisco: Announcement on the capital reduction of its subsidiary Shenyang Hisco
Feb 27 11:00 ET
HiCisco: Announcement on capital increase for the subsidiary HiCisco of the United States
Feb 27 11:00 ET
HiCisco: Announcement on Resignation of Director
Feb 23 11:00 ET
HiCisco: Announcement on Obtaining the “Notice of Acceptance” of the IND Application for the New Indication of the Innovative Drug HSK31858 Tablets
Jan 31 11:00 ET
HiCisco: Announcement on Obtaining the “Notice of Acceptance” of the IND Application for New Indications for the Innovative Drug HSK16149 Capsules
Jan 30 11:00 ET
HiCisco: Announcement on the establishment of a wholly-owned subsidiary in Australia
Jan 30 11:00 ET
HiCisco: Announcement on the progress of establishing a subsidiary in Shannan City, Tibet Autonomous Region
Jan 26 11:00 ET
HiCisco: Announcement on Obtaining the “Notice of Acceptance” of the IND Application for the New Indication of the Innovative Drug HSK31858 Tablets
Jan 21 11:00 ET
No Data
No Data